⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRB News
Spruce Biosciences, Inc. Common Stock
Spruce Biosciences Announces Long-Term Tralesinidase Alfa Enzyme Replacement Therapy Data in Sanfilippo Syndrome Type B (MPS IIIB) Presented at the 18th International MPS Symposium
businesswire.com
SPRB
Spruce Biosciences Announces Data Presentation at the 18th International MPS Symposium
businesswire.com
SPRB
Spruce Biosciences to Participate in Upcoming Conferences in June
businesswire.com
SPRB
Form 8-K
sec.gov
SPRB
Form 8-K
sec.gov
SPRB
Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
businesswire.com
SPRB
Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors
globenewswire.com
SPRB
Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations
businesswire.com
SPRB
Form 8-K
sec.gov
SPRB
Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
businesswire.com
SPRB